News

Patients with hormone receptor positive (HR+) breast cancer should have been treated with a prior endocrine therapy or be considered inappropriate for endocrine therapy. Patients are selected for

The partnership intends to develop a complete and final manufacturing process to enable CombiGene advance to commercial good manufacturing practices (GMP) production and subsequent clinical trials. CGT Catapult believes that

The subpoena broadly requests documents including, among others, those produced in past or pending lawsuits and those relating to product safety and efficacy, overdoses, diversion, thefts, overprescribing, abuse/misuse,

KWS BioTest specializes in in vitro and in vivo discovery testing services for immuno-oncology, inflammation and allergy, autoimmune disease and antimicrobials, antivirals, and vaccinology. The acquisition is expected to

BRUDAC’s panel voted six in favor and thirteen against the benefit/risk profile of the company’s oral testosterone product candidate for testosterone replacement therapy (TRT) in adult males for

The PQBirch301 study is a pivotal Phase III study designed to evaluate the safety and efficacy of the Group's ultra-short course, convenient for patients, aluminium free PQ Birch

GryNumber is one of the leading healthcare consultancy and distribution companies in the region, with many years of experience. The agreement covers the distribution of Lojuxta across Austria,

The approval is for the treatment of adult patients in whom the condition is inadequately controlled even after being subjected to high-dose inhaled corticosteroids and long-acting beta-agonists. The

The trial (known as BGBC004) is designed to test the hypothesis that selective AXL inhibition with the once-daily oral small molecule bemcentinib may reverse and prevent resistance to